BioLife Solutions (BLFS)
(Delayed Data from NSDQ)
$24.21 USD
+1.02 (4.40%)
Updated Sep 12, 2024 03:57 PM ET
After-Market: $24.27 +0.06 (0.25%) 4:36 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$24.21 USD
+1.02 (4.40%)
Updated Sep 12, 2024 03:57 PM ET
After-Market: $24.27 +0.06 (0.25%) 4:36 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Zacks News
Bull Run to Continue in Rest of 2018: 5 Terrific Growth Picks
by Nalak Das
Strong economic fundamentals of the United States suggest that the recent volatility may be transitory and that markets will continue their uptrend.
Medtronic (MDT) Surges: Stock Moves 5.7% Higher
by Zacks Equity Research
Medtronic (MDT) was a big mover last session, as the company saw its shares rise more than 5% on the day amid huge volumes.
PetIQ (PETQ) Catches Eye: Stock Jumps 9.1%
by Zacks Equity Research
PetIQ (PETQ) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Canopy Growth (CGC) in Focus: Stock Moves 9.2% Higher
by Zacks Equity Research
Canopy Growth (CGC) shares rose more than 9% in the last trading session, amid huge volumes.
GW Pharma (GWPH) Q3 Earnings: Is a Turnaround in the Cards?
by Zacks Equity Research
GW Pharma (GWPH) is expected to report its fiscal third-quarter results next week. Investors focus is expected to be on the commercialization plan for Epidiolex.
Top Ranked Momentum Stocks to Buy for August 6th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 6th:
Top Ranked Momentum Stocks to Buy for August 3rd
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 3rd:
Top Ranked Momentum Stocks to Buy for July 27th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 27th:
Top Ranked Momentum Stocks to Buy for July 26th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 26th:
Has BioLife Solutions (BLFS) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (BLFS) Outperforming Other Medical Stocks This Year?
Top Ranked Momentum Stocks to Buy for July 18th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 18th:
Zacks.com featured highlights include: CNX, Radcom, BioLife, Momo and Atlas Air
by Zacks Equity Research
Zacks.com featured highlights include: CNX, Radcom, BioLife, Momo and Atlas Air
Improve Your Portfolio With These 5 Top Profitable Stocks
by Zacks Equity Research
Profitability analysis is the best way to evaluate a company's ability to provide healthy gains to its investors even after meeting all its business-related expenses.
Top Ranked Momentum Stocks to Buy for July 13th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 13th:
New Strong Buy Stocks for July 13th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
Top Ranked Momentum Stocks to Buy for July 10th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 10th:
Top Ranked Momentum Stocks to Buy for July 5th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 5th:
Can The Uptrend Continue for BioLife Solutions (BLFS)?
by Zacks Equity Research
BioLife Solutions, Inc. (BLFS) has been on the move lately as the stock has risen by 44.6% in the past four weeks
Surmodics (SRDX) Hits Fresh Highs: Is There Still Room to Run?
by Zacks Equity Research
Surmodics, Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for SRDX for clues.
Baxter International (BAX) Hits a 52-Week High, Can the Run Continue?
by Zacks Equity Research
Baxter International Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for BAX for clues.
BioLife Solutions (BLFS) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in BioLife Solutions, Inc. (BLFS)
The Zacks Analyst Blog Highlights: BioLife Solutions, SeaSpine Holdings, Apollo Endosurgery and CareDx
by Zacks Equity Research
The Zacks Analyst Blog Highlights: BioLife Solutions, SeaSpine Holdings, Apollo Endosurgery and CareDx
4 Top-Ranked Growth Stocks in MedTech Under $20
by Zacks Equity Research
In the wake of the turbulent political scenario and banking on favorable metrics, these four MedTech stocks stand out as the most suitable picks.
Zacks.com featured highlights: H&E Equipment Services, Nomad Foods, Strayer Education, BioLife Solutions and Assembly Biosciences
by Zacks Equity Research
Zacks.com featured highlights: H&E Equipment Services, Nomad Foods, Strayer Education, BioLife Solutions and Assembly Biosciences
New Analyst Coverage Puts the Spotlight on These 5 Stocks
by Zacks Equity Research
Increased analyst coverage over the last few weeks might translate into solid price appreciation for these stocks.